Silynxcom director discloses options on 26,840 shares

Silynxcom Ltd. director Yossi Tisch filed an initial Form 3 disclosing a derivative equity position.

Rhea-AI Filing Summary

Silynxcom Ltd. director Yossi Tisch filed an initial Form 3 disclosing a derivative equity position. He holds share options giving the right to buy 26,840 ordinary shares at an exercise price of $4.00 per share, expiring on January 31, 2029.

According to the footnote, these options were granted on January 31, 2024 and vest in three equal annual installments beginning January 30, 2025 and continuing through January 30, 2027. The filing reports holdings only and does not show any recent purchases or sales.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Tisch Yossi

Role Director

Type	Security	Shares	Price	Value
holding	Share options (right to buy)	--	--	--

Holdings After Transaction: Share options (right to buy) — 26,840 contracts (Direct)

Footnotes (1)

1. F1. The options were granted on January 31, 2024, and vest in three equal annual installments, beginning January 30, 2025, until January 30, 2027.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Yossi Tisch’s Form 3 for Silynxcom (SYNX) disclose?

The Form 3 reports Yossi Tisch’s initial beneficial ownership in Silynxcom. It shows he holds options over 26,840 ordinary shares at $4.00 per share, expiring in 2029, with vesting between 2025 and 2027.

How many Silynxcom (SYNX) shares are covered by Yossi Tisch’s options?

The options disclosed cover 26,840 underlying ordinary shares. These are not shares currently owned outright, but shares that can potentially be purchased through exercising the options, subject to vesting and the $4.00 exercise price.

What is the exercise price and expiration for Yossi Tisch’s Silynxcom options?

The options have an exercise price of $4.00 per share and an expiration date of January 31, 2029. This means he can choose to buy the underlying shares at $4.00 any time after vesting and before expiration.

How do the Silynxcom (SYNX) options granted to Yossi Tisch vest?

The options were granted on January 31, 2024 and vest in three equal annual installments. Vesting begins on January 30, 2025 and continues on January 30, 2026 and January 30, 2027, gradually making more options exercisable.

Does Yossi Tisch’s Form 3 for Silynxcom show any recent share purchases or sales?

The Form 3 does not show any recent share purchases or sales. It lists an existing holding of share options, classified as a holding entry, rather than a new transaction that increased or decreased his Silynxcom equity exposure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/19/2026 - 06:32 AM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Tisch Yossi

(Last) (First) (Middle)

7 GIBOREI ISRAEL

(Street)

NETANYA 4250407

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Silynxcom Ltd. [ SYNX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Share options (right to buy)(1)	01/30/2025	01/31/2029	Ordinary Shares, no par value per share	26,840	$4	D

Explanation of Responses:

1. The options were granted on January 31, 2024, and vest in three equal annual installments, beginning January 30, 2025, until January 30, 2027.

	/s/ Yossi Tisch	03/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)